nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—Sparfloxacin—ABCB1—peripheral nervous system neoplasm	0.00214	0.419	CrCbGaD
Gatifloxacin—Levofloxacin—ABCB1—peripheral nervous system neoplasm	0.0015	0.295	CrCbGaD
Gatifloxacin—Ciprofloxacin—ABCB1—peripheral nervous system neoplasm	0.00145	0.285	CrCbGaD
Gatifloxacin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000646	0.000649	CcSEcCtD
Gatifloxacin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000646	0.000649	CcSEcCtD
Gatifloxacin—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000645	0.000648	CcSEcCtD
Gatifloxacin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000644	0.000647	CcSEcCtD
Gatifloxacin—Constipation—Vincristine—peripheral nervous system neoplasm	0.000644	0.000647	CcSEcCtD
Gatifloxacin—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000644	0.000647	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000644	0.000647	CcSEcCtD
Gatifloxacin—Rash—Melphalan—peripheral nervous system neoplasm	0.000642	0.000645	CcSEcCtD
Gatifloxacin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000641	0.000644	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000639	0.000642	CcSEcCtD
Gatifloxacin—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000638	0.000641	CcSEcCtD
Gatifloxacin—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000636	0.000639	CcSEcCtD
Gatifloxacin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000635	0.000638	CcSEcCtD
Gatifloxacin—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000633	0.000637	CcSEcCtD
Gatifloxacin—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000622	0.000625	CcSEcCtD
Gatifloxacin—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000622	0.000625	CcSEcCtD
Gatifloxacin—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000621	0.000624	CcSEcCtD
Gatifloxacin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000621	0.000624	CcSEcCtD
Gatifloxacin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000621	0.000624	CcSEcCtD
Gatifloxacin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000618	0.000621	CcSEcCtD
Gatifloxacin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000618	0.000621	CcSEcCtD
Gatifloxacin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000617	0.00062	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000616	0.000619	CcSEcCtD
Gatifloxacin—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000616	0.000619	CcSEcCtD
Gatifloxacin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000615	0.000618	CcSEcCtD
Gatifloxacin—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000613	0.000617	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000613	0.000617	CcSEcCtD
Gatifloxacin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000612	0.000615	CcSEcCtD
Gatifloxacin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000612	0.000615	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00061	0.000613	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000606	0.00061	CcSEcCtD
Gatifloxacin—Infection—Etoposide—peripheral nervous system neoplasm	0.000606	0.000609	CcSEcCtD
Gatifloxacin—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000605	0.000608	CcSEcCtD
Gatifloxacin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000605	0.000608	CcSEcCtD
Gatifloxacin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000604	0.000608	CcSEcCtD
Gatifloxacin—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000601	0.000604	CcSEcCtD
Gatifloxacin—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000601	0.000604	CcSEcCtD
Gatifloxacin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000598	0.000601	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000597	0.0006	CcSEcCtD
Gatifloxacin—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000595	0.000598	CcSEcCtD
Gatifloxacin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000595	0.000598	CcSEcCtD
Gatifloxacin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000595	0.000598	CcSEcCtD
Gatifloxacin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000593	0.000597	CcSEcCtD
Gatifloxacin—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.00059	0.000593	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00059	0.000593	CcSEcCtD
Gatifloxacin—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000589	0.000592	CcSEcCtD
Gatifloxacin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000581	0.000584	CcSEcCtD
Gatifloxacin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000579	0.000582	CcSEcCtD
Gatifloxacin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000577	0.000579	CcSEcCtD
Gatifloxacin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000576	0.000579	CcSEcCtD
Gatifloxacin—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000575	0.000578	CcSEcCtD
Gatifloxacin—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00057	0.000573	CcSEcCtD
Gatifloxacin—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.00057	0.000572	CcSEcCtD
Gatifloxacin—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000568	0.000571	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000568	0.000571	CcSEcCtD
Gatifloxacin—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000562	0.000565	CcSEcCtD
Gatifloxacin—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000562	0.000565	CcSEcCtD
Gatifloxacin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000561	0.000563	CcSEcCtD
Gatifloxacin—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000556	0.000559	CcSEcCtD
Gatifloxacin—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000556	0.000559	CcSEcCtD
Gatifloxacin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000555	0.000558	CcSEcCtD
Gatifloxacin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000553	0.000556	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000549	0.000552	CcSEcCtD
Gatifloxacin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000549	0.000551	CcSEcCtD
Gatifloxacin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000548	0.00055	CcSEcCtD
Gatifloxacin—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000545	0.000548	CcSEcCtD
Gatifloxacin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000544	0.000546	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000542	0.000545	CcSEcCtD
Gatifloxacin—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000542	0.000545	CcSEcCtD
Gatifloxacin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00054	0.000543	CcSEcCtD
Gatifloxacin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000536	0.000538	CcSEcCtD
Gatifloxacin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000535	0.000537	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000531	0.000534	CcSEcCtD
Gatifloxacin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000531	0.000534	CcSEcCtD
Gatifloxacin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00053	0.000533	CcSEcCtD
Gatifloxacin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000526	0.000529	CcSEcCtD
Gatifloxacin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000522	0.000525	CcSEcCtD
Gatifloxacin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000522	0.000524	CcSEcCtD
Gatifloxacin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000521	0.000524	CcSEcCtD
Gatifloxacin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.00052	0.000523	CcSEcCtD
Gatifloxacin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.00052	0.000523	CcSEcCtD
Gatifloxacin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000517	0.000519	CcSEcCtD
Gatifloxacin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000515	0.000518	CcSEcCtD
Gatifloxacin—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000514	0.000516	CcSEcCtD
Gatifloxacin—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000511	0.000514	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000508	0.00051	CcSEcCtD
Gatifloxacin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000506	0.000508	CcSEcCtD
Gatifloxacin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000503	0.000505	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000502	0.000504	CcSEcCtD
Gatifloxacin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000501	0.000503	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000499	0.000501	CcSEcCtD
Gatifloxacin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000498	0.0005	CcSEcCtD
Gatifloxacin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000497	0.000499	CcSEcCtD
Gatifloxacin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000493	0.000495	CcSEcCtD
Gatifloxacin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000492	0.000495	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000492	0.000494	CcSEcCtD
Gatifloxacin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00049	0.000493	CcSEcCtD
Gatifloxacin—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00049	0.000492	CcSEcCtD
Gatifloxacin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000489	0.000492	CcSEcCtD
Gatifloxacin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000484	0.000487	CcSEcCtD
Gatifloxacin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000483	0.000486	CcSEcCtD
Gatifloxacin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000482	0.000485	CcSEcCtD
Gatifloxacin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000482	0.000485	CcSEcCtD
Gatifloxacin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000482	0.000485	CcSEcCtD
Gatifloxacin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000481	0.000484	CcSEcCtD
Gatifloxacin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000479	0.000481	CcSEcCtD
Gatifloxacin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000478	0.00048	CcSEcCtD
Gatifloxacin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000478	0.00048	CcSEcCtD
Gatifloxacin—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000475	0.000478	CcSEcCtD
Gatifloxacin—Rash—Vincristine—peripheral nervous system neoplasm	0.000475	0.000477	CcSEcCtD
Gatifloxacin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000474	0.000477	CcSEcCtD
Gatifloxacin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000474	0.000476	CcSEcCtD
Gatifloxacin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000473	0.000475	CcSEcCtD
Gatifloxacin—Headache—Vincristine—peripheral nervous system neoplasm	0.000472	0.000474	CcSEcCtD
Gatifloxacin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000468	0.00047	CcSEcCtD
Gatifloxacin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000464	0.000466	CcSEcCtD
Gatifloxacin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000464	0.000466	CcSEcCtD
Gatifloxacin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000455	0.000458	CcSEcCtD
Gatifloxacin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000455	0.000457	CcSEcCtD
Gatifloxacin—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.000456	CcSEcCtD
Gatifloxacin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.00045	0.000452	CcSEcCtD
Gatifloxacin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000449	0.000452	CcSEcCtD
Gatifloxacin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000449	0.000451	CcSEcCtD
Gatifloxacin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000447	0.000449	CcSEcCtD
Gatifloxacin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000447	CcSEcCtD
Gatifloxacin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000442	0.000444	CcSEcCtD
Gatifloxacin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000439	0.000441	CcSEcCtD
Gatifloxacin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000438	0.00044	CcSEcCtD
Gatifloxacin—Chills—Epirubicin—peripheral nervous system neoplasm	0.000432	0.000434	CcSEcCtD
Gatifloxacin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000431	0.000434	CcSEcCtD
Gatifloxacin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000429	0.000431	CcSEcCtD
Gatifloxacin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000423	0.000425	CcSEcCtD
Gatifloxacin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000421	0.000423	CcSEcCtD
Gatifloxacin—Rash—Cisplatin—peripheral nervous system neoplasm	0.00042	0.000422	CcSEcCtD
Gatifloxacin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000419	0.000421	CcSEcCtD
Gatifloxacin—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000419	0.000421	CcSEcCtD
Gatifloxacin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000417	0.000419	CcSEcCtD
Gatifloxacin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000416	0.000418	CcSEcCtD
Gatifloxacin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000417	CcSEcCtD
Gatifloxacin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000413	0.000415	CcSEcCtD
Gatifloxacin—Tension—Epirubicin—peripheral nervous system neoplasm	0.000411	0.000413	CcSEcCtD
Gatifloxacin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00041	0.000412	CcSEcCtD
Gatifloxacin—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000407	0.000409	CcSEcCtD
Gatifloxacin—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000405	0.000407	CcSEcCtD
Gatifloxacin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000403	0.000405	CcSEcCtD
Gatifloxacin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000403	0.000405	CcSEcCtD
Gatifloxacin—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.000402	CcSEcCtD
Gatifloxacin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000395	0.000397	CcSEcCtD
Gatifloxacin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000395	0.000397	CcSEcCtD
Gatifloxacin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000388	0.00039	CcSEcCtD
Gatifloxacin—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000388	0.00039	CcSEcCtD
Gatifloxacin—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000385	0.000387	CcSEcCtD
Gatifloxacin—Rash—Etoposide—peripheral nervous system neoplasm	0.000385	0.000386	CcSEcCtD
Gatifloxacin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000384	0.000386	CcSEcCtD
Gatifloxacin—Headache—Etoposide—peripheral nervous system neoplasm	0.000382	0.000384	CcSEcCtD
Gatifloxacin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.000384	CcSEcCtD
Gatifloxacin—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.000382	CcSEcCtD
Gatifloxacin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.000381	CcSEcCtD
Gatifloxacin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.000378	CcSEcCtD
Gatifloxacin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000376	0.000378	CcSEcCtD
Gatifloxacin—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000376	0.000378	CcSEcCtD
Gatifloxacin—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000375	0.000377	CcSEcCtD
Gatifloxacin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.000375	CcSEcCtD
Gatifloxacin—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00037	0.000372	CcSEcCtD
Gatifloxacin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000368	0.00037	CcSEcCtD
Gatifloxacin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000365	0.000367	CcSEcCtD
Gatifloxacin—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000365	CcSEcCtD
Gatifloxacin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000362	0.000364	CcSEcCtD
Gatifloxacin—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000362	0.000363	CcSEcCtD
Gatifloxacin—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000358	CcSEcCtD
Gatifloxacin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000358	CcSEcCtD
Gatifloxacin—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000358	CcSEcCtD
Gatifloxacin—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.000358	CcSEcCtD
Gatifloxacin—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000355	0.000357	CcSEcCtD
Gatifloxacin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.00035	CcSEcCtD
Gatifloxacin—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000349	CcSEcCtD
Gatifloxacin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000346	CcSEcCtD
Gatifloxacin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.000344	CcSEcCtD
Gatifloxacin—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000344	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000344	CcSEcCtD
Gatifloxacin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.000342	CcSEcCtD
Gatifloxacin—Infection—Epirubicin—peripheral nervous system neoplasm	0.00034	0.000341	CcSEcCtD
Gatifloxacin—Shock—Epirubicin—peripheral nervous system neoplasm	0.000336	0.000338	CcSEcCtD
Gatifloxacin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000338	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000336	CcSEcCtD
Gatifloxacin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.000336	CcSEcCtD
Gatifloxacin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000334	0.000335	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000332	CcSEcCtD
Gatifloxacin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.000332	CcSEcCtD
Gatifloxacin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.000332	CcSEcCtD
Gatifloxacin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.000332	CcSEcCtD
Gatifloxacin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.00033	CcSEcCtD
Gatifloxacin—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000328	CcSEcCtD
Gatifloxacin—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000319	0.000321	CcSEcCtD
Gatifloxacin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000321	CcSEcCtD
Gatifloxacin—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000318	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000318	CcSEcCtD
Gatifloxacin—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.000316	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000313	CcSEcCtD
Gatifloxacin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.000313	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.000311	CcSEcCtD
Gatifloxacin—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000311	CcSEcCtD
Gatifloxacin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.00031	CcSEcCtD
Gatifloxacin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000309	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000307	CcSEcCtD
Gatifloxacin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000306	CcSEcCtD
Gatifloxacin—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000305	CcSEcCtD
Gatifloxacin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000303	CcSEcCtD
Gatifloxacin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000302	CcSEcCtD
Gatifloxacin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000297	0.000299	CcSEcCtD
Gatifloxacin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000297	CcSEcCtD
Gatifloxacin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000294	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.00029	CcSEcCtD
Gatifloxacin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000288	CcSEcCtD
Gatifloxacin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000285	CcSEcCtD
Gatifloxacin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000283	CcSEcCtD
Gatifloxacin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000283	CcSEcCtD
Gatifloxacin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000283	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000281	CcSEcCtD
Gatifloxacin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.00028	CcSEcCtD
Gatifloxacin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000276	CcSEcCtD
Gatifloxacin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000273	CcSEcCtD
Gatifloxacin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000272	CcSEcCtD
Gatifloxacin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000272	CcSEcCtD
Gatifloxacin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000272	CcSEcCtD
Gatifloxacin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000262	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.00026	CcSEcCtD
Gatifloxacin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000253	CcSEcCtD
Gatifloxacin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000253	CcSEcCtD
Gatifloxacin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000251	CcSEcCtD
Gatifloxacin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000251	CcSEcCtD
Gatifloxacin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000247	CcSEcCtD
Gatifloxacin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000243	CcSEcCtD
Gatifloxacin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000235	CcSEcCtD
Gatifloxacin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000234	CcSEcCtD
Gatifloxacin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000228	CcSEcCtD
Gatifloxacin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000227	CcSEcCtD
Gatifloxacin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000225	CcSEcCtD
Gatifloxacin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000218	CcSEcCtD
Gatifloxacin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000218	CcSEcCtD
Gatifloxacin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000217	CcSEcCtD
Gatifloxacin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000216	CcSEcCtD
Gatifloxacin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000215	CcSEcCtD
Gatifloxacin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.00021	CcSEcCtD
Gatifloxacin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000204	CcSEcCtD
Gatifloxacin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000202	CcSEcCtD
Gatifloxacin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.0002	CcSEcCtD
Gatifloxacin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.0002	CcSEcCtD
Gatifloxacin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000199	CcSEcCtD
Gatifloxacin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000189	CcSEcCtD
